Cargando…
Effect of Nimodipine Treatment on the Clinical Course of Reversible Cerebral Vasoconstriction Syndrome
Background: In reversible cerebral vasoconstriction syndrome (RCVS), nimodipine is currently used for the treatment, although no evidence is available to support its disease-modifying effect. In this prospective observational study, we investigated whether earlier nimodipine treatment can modify the...
Autores principales: | Cho, Soohyun, Lee, Mi Ji, Chung, Chin-Sang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6591369/ https://www.ncbi.nlm.nih.gov/pubmed/31275233 http://dx.doi.org/10.3389/fneur.2019.00644 |
Ejemplares similares
-
No Association of RNF213 Polymorphism with Reversible Cerebral Vasoconstriction Syndrome
por: Song, Joomee, et al.
Publicado: (2020) -
RCVS–TCH score can predict reversible cerebral vasoconstriction syndrome in patients with thunderclap headache
por: Cho, Soohyun, et al.
Publicado: (2021) -
COVID-19 Associated Reversible Cerebral Vasoconstriction Syndrome Successfully Treated with Nimodipine and Aspirin
por: Mansoor, Tarab, et al.
Publicado: (2021) -
Posterior Reversible Encephalopathy Syndrome and Reversible Cerebral Vasoconstriction Syndrome: Clinical and Radiological Considerations
por: Pilato, Fabio, et al.
Publicado: (2020) -
Leptomeningeal Carcinomatosis Mimicking Reversible Cerebral Vasoconstriction Syndrome
por: Grewal, Parneet, et al.
Publicado: (2022)